Company intelligence / Profile preview

Qingdao Hightop Biotech

Ownership: Private
Development stage: Commercial

Overview

Qingdao Hightop Biotech develops and manufactures a broad portfolio of in vitro diagnostic products—including rapid tests for infectious diseases like HIV/AIDS and COVID‑19—ELISA kits for serological testing of various pathogens and analytes. Their products have received CE marking and ISO certifications. The company’s SARS-CoV‑2 RT-PCR detection kits demonstrated high sensitivity/specificity in independent evaluations. They are among China’s largest manufacturers of diagnostics with global distribution to the US/EU/Middle East/Africa/South America markets.

Therapeutic areas: Infectious DiseasesWomen's Health
Modalities: Diagnostic test kitELISA kitRapid test kitChemistry reagent/assayMedical device/instrument
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Qingdao Hightop Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingdao Hightop Biotech.

Explore the full profile